Evidence Hub

Lipiodol-Mediated Dose Enhancement in Radiation Therapy: A Phantom and In Vitro Study in Hepatocellular Carcinoma

Yamada K, Michimoto K, Anoushiravani A, Suzuki T, Graham T, Bunker A, Bertinetti A, Nabavizadeh N et al.

Cardiovascular and interventional radiology, 2026

1 citation

Abstract

PURPOSE: To assess Lipiodol-mediated photon dose perturbation and biological effects using complementary kilovoltage and megavoltage irradiation geometries relevant to hepatocellular carcinoma.

MATERIALS AND METHODS: Phantom dosimetry used containers filled with lipiodol-oil mixtures (0-100%) embedded in a water phantom with radiochromic film to quantify concentration-dependent enhancement under 6-MV beam. HepG2 human hepatoma cells were irradiated at 0-6 Gy using 160-kVp (photoelectric effect dominant) with lipiodol or water placed beneath the cell monolayer to isolate backscatter; γH2AX foci indicating DNA damage were quantified shortly after irradiation. For megavoltage testing, a 6-MV (Compton scattering dominant) Lipiodol-rich "sandwich" geometry (Lipiodol above and below the cell monolayer) was used; apoptosis was quantified at 96 h using NucView/NucSpot (apoptotic fraction), and results are reported descriptively.

RESULTS: Film dosimetry demonstrated increasing enhancement with Lipiodol concentration, spatially localized to the Lipiodol region, with a maximum localized increase of 57.1% at 100% Lipiodol versus water. In the 160-kVp backscatter model, higher γH2AX foci were observed at 4 and 6 Gy in Lipiodol versus control. In the 6-MV sandwich model, cell-plane film confirmed an 11.5% higher delivered dose at 2 Gy with Lipiodol and apoptotic fraction was 1.36-5.79-fold higher across 2-6 Gy compared to the control.

CONCLUSION: Lipiodol measurably intensified local…

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free